[1] J.J. Chae-Kim, L. Gavrilova-Jordan (2018) Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies, Biomedicines. 7.http://10.3390/biomedicines7010002.
[2] L. Webber, M. Davies, R. Anderson, J. Bartlett, D. Braat, B. Cartwright, R. Cifkova, S. de Muinck Keizer-Schrama, E. Hogervorst, F. Janse, L. Liao, V. Vlaisavljevic, C. Zillikens, N. Vermeulen (2016) ESHRE Guideline: management of women with premature ovarian insufficiency, Hum Reprod. 31: 926-37.http://10.1093/humrep/dew027.
[3] K. Lagergren, M. Hammar, E. Nedstrand, M. Bladh, G. Sydsjö (2018) The prevalence of primary ovarian insufficiency in Sweden; a national register study, BMC Womens Health. 18: 175.http://10.1186/s12905-018-0665-2.
[4] E. Løkkegaard, Z. Jovanovic, B.L. Heitmann, N. Keiding, B. Ottesen, A.T. Pedersen (2006) The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy, Maturitas. 53: 226-33.http://10.1016/j.maturitas.2005.04.009.
[5] Y.J. Jeon, Y. Choi, S.H. Shim, Y.S. Choi, J.J. Ko, T.K. Yoon, S.H. Cha, N.K. Kim (2011) Vascular endothelial growth factor gene polymorphisms in Korean patients with premature ovarian failure, Eur J Obstet Gynecol Reprod Biol. 159: 138-42.http://10.1016/j.ejogrb.2011.07.007.
[6] R.J. Baber, N. Panay, A. Fenton (2016) 2016 IMS Recommendations on women's midlife health and menopause hormone therapy, Climacteric. 19: 109-50.http://10.3109/13697137.2015.1129166.
[7] S. Dragojević Dikić, M. Vasiljević, A. Jovanović, S. Dikić, A. Jurišić, L. Srbinović, S. Vujović (2020) Premature ovarian insufficiency - novel hormonal approaches in optimizing fertility, Gynecol Endocrinol. 36: 162-165.http://10.1080/09513590.2019.1640203.
[8] Z. Yuanyuan, W. Jiaman, Q. Yimin, Y. Haibo, Y. Weiqu, Y. Zhuoxin (2020) Comparison of Prediction Models based on Risk Factors and Retinal Characteristics Associated with Recurrence One Year after Ischemic Stroke, J Stroke Cerebrovasc Dis. 29: 104581.http://10.1016/j.jstrokecerebrovasdis.2019.104581.
[9] Y. Zhuo, J. Wu, Y. Qu, H. Yu, X. Huang, B. Zee, J. Lee, Z. Yang (2020) Clinical risk factors associated with recurrence of ischemic stroke within two years: A cohort study, Medicine (Baltimore). 99: e20830.http://10.1097/md.0000000000020830.
[10] Y.Y. Zhuo, J.M. Wu, L. Kuang, Y.M. Qu, B. Zee, J. Lee, Z.X. Yang (2020) The Discriminative Efficacy of Retinal Characteristics on Two Traditional Chinese Syndromes in Association with Ischemic Stroke, Evid Based Complement Alternat Med. 2020: 6051831.http://10.1155/2020/6051831.
[11] C.Y. Zee, J.W. Lee, E.Q. Li (2014) Method and device for retinal image analysis, US.
[12] M.D. Knudtson, K.E. Lee, L.D. Hubbard, T.Y. Wong, R. Klein, B.E. Klein (2003) Revised formulas for summarizing retinal vessel diameters, Curr Eye Res. 27: 143-9.http://10.1076/ceyr.27.3.143.16049.
[13] G.M. Rubanyi, A. Johns, K. Kauser (2002) Effect of estrogen on endothelial function and angiogenesis, Vascul Pharmacol. 38: 89-98.http://10.1016/s0306-3623(02)00131-3.
[14] A. Radu, C. Pichon, P. Camparo, M. Antoine, Y. Allory, A. Couvelard, G. Fromont, M.T. Hai, N. Ghinea (2010) Expression of follicle-stimulating hormone receptor in tumor blood vessels, N Engl J Med. 363: 1621-30.http://10.1056/NEJMoa1001283.
[15] F. Naftolin, J. Friedenthal, R. Nachtigall, L. Nachtigall (2019) Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment, F1000Res. 8.http://10.12688/f1000research.15548.1.
[16] K. Raizada, K. Tripathy, Eales Disease, StatPearls, StatPearls Publishing
Copyright © 2021, StatPearls Publishing LLC., Treasure Island (FL), 2021.
[17] M. Harris-Yitzhak, A. Harris, Z. Ben-Refael, D. Zarfati, H.J. Garzozi, B.J. Martin (2000) Estrogen-replacement therapy: effects on retrobulbar hemodynamics, Am J Ophthalmol. 129: 623-8.http://10.1016/s0002-9394(99)00468-7.
[18] T.Z. Movsas, R. Sigler, A. Muthusamy (2018) Elimination of Signaling by the Luteinizing Hormone Receptor Reduces Ocular VEGF and Retinal Vascularization during Mouse Eye Development, Curr Eye Res. 43: 1286-1289.http://10.1080/02713683.2018.1495740.
[19] B. Vannier, H. Loosfelt, G. Meduri, C. Pichon, E. Milgrom (1996) Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor, Biochemistry. 35: 1358-66.http://10.1021/bi952290f.
[20] M.T. Vu Hai, P. Lescop, H. Loosfelt, N. Ghinea (2004) Receptor-mediated transcytosis of follicle-stimulating hormone through the rat testicular microvasculature, Biol Cell. 96: 133-44.http://10.1016/j.biolcel.2003.11.008.
[21] Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–574 . https://doi.org/10.1210/er.2007-0001.
[22] Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Heart Circ Physiol. 2018;315(6):H1569–H1588. https://doi.org/10.1152/ajpheart.00396.2018
[23] Huang Y, Hu C, Ye H, et al. Inflamm-aging: a new mechanism affecting premature ovarian insufficiency. J Immunol Res. 2019; 2019:8069898. https://doi.org/10.1155/2019/8069898
[24] Kok HS, van Asselt KM, van der Schouw YT, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol. 2006;47(10):1976–1983. https://doi.org/10.1016/j.jacc.2005.12.066
[25] Laven JSE, Visser JA, Uitterlinden AG, et al. Menopause: genome stability as new paradigm. Maturitas. 2016;92:15–23. https://doi.org/10.1016/j.maturitas.2016.07.006
[26] Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004;89(8):3907–3913. https://doi.org/10.1210/jc.2004-0015
[27] M.H. Errera, A. Pratas, P. Goldschmidt, N. Sedira, J.A. Sahel, J. Benesty (2016) [Eales' disease], J Fr Ophtalmol. 39: 474-82.http://10.1016/j.jfo.2016.03.001.
[28] J.K. Shrestha, D. Khadka, G. Lamichhane, S. Khanal (2009) Retinal vasculitis, Nepal J Ophthalmol. 1: 66-71.http://10.3126/nepjoph.v1i1.3675.
[29] F. Paneni, C. Diaz Cañestro, P. Libby, T.F. Lüscher, G.G. Camici (2017) The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels, J Am Coll Cardiol. 69: 1952-1967.http://10.1016/j.jacc.2017.01.064.
[30] A. de Almeida, T.P. Ribeiro, I.A. de Medeiros (2017) Aging: Molecular Pathways and Implications on the Cardiovascular System, Oxid Med Cell Longev. 2017: 7941563.http://10.1155/2017/7941563.